LM Advisors LLC bought a new position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 9,479 shares of the financial services provider’s stock, valued at approximately $1,288,000. Several other institutional investors have also […]
908 Devices Inc. (NASDAQ:MASS – Get Free Report) was the target of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 1,050,000 shares, a decrease of 21.6% from the April 30th total of 1,340,000 shares. Approximately 4.2% of the shares of the stock are […]
Citigroup initiated coverage on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a research note issued to investors on Wednesday, Marketbeat reports. The brokerage issued a sell rating and a $8.00 price target on the biopharmaceutical company’s stock. SAGE has been the subject of several other reports. The Goldman Sachs Group decreased their price […]
Baird R W upgraded shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) to a hold rating in a research note issued to investors on Wednesday, Zacks.com reports. A number of other analysts have also weighed in on the company. Wedbush reaffirmed a neutral rating and set a $24.00 price objective on shares of Sage Therapeutics […]
Swiss National Bank reduced its position in Central Garden & Pet (NASDAQ:CENT – Free Report) by 11.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,550 shares of the company’s stock after selling 2,300 shares during the period. Swiss […]